FR2930943B1 - Nouvelles utilisations de derives de d-mannopyranose inhibiteurs de l'angiogenese - Google Patents
Nouvelles utilisations de derives de d-mannopyranose inhibiteurs de l'angiogeneseInfo
- Publication number
- FR2930943B1 FR2930943B1 FR0802537A FR0802537A FR2930943B1 FR 2930943 B1 FR2930943 B1 FR 2930943B1 FR 0802537 A FR0802537 A FR 0802537A FR 0802537 A FR0802537 A FR 0802537A FR 2930943 B1 FR2930943 B1 FR 2930943B1
- Authority
- FR
- France
- Prior art keywords
- mannopyranosis
- angiogenesis
- novel uses
- derivatives inhibitors
- inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
- C07H11/04—Phosphates; Phosphites; Polyphosphates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/12—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
- C07H7/02—Acyclic radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0802537A FR2930943B1 (fr) | 2008-05-07 | 2008-05-07 | Nouvelles utilisations de derives de d-mannopyranose inhibiteurs de l'angiogenese |
CA2723768A CA2723768A1 (fr) | 2008-05-07 | 2009-05-05 | Nouvelles utilisations de derives de d-mannopyranose |
JP2011507963A JP2011520803A (ja) | 2008-05-07 | 2009-05-05 | D−マンノピラノース誘導体 |
EP09745920A EP2280985A2 (fr) | 2008-05-07 | 2009-05-05 | Utilisation de derives de mannose-6-phosphate pour le contrôle de l'angiogénèse et la regénération ligamentaire et la reconstruction de cartilage |
PCT/FR2009/000525 WO2009138601A2 (fr) | 2008-05-07 | 2009-05-05 | Nouvelles utilisations de derives de d-mannopyranose |
US12/991,631 US20110112044A1 (en) | 2008-05-07 | 2009-05-05 | Novel uses of d-mannopyranose derivatives |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0802537A FR2930943B1 (fr) | 2008-05-07 | 2008-05-07 | Nouvelles utilisations de derives de d-mannopyranose inhibiteurs de l'angiogenese |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2930943A1 FR2930943A1 (fr) | 2009-11-13 |
FR2930943B1 true FR2930943B1 (fr) | 2011-03-18 |
Family
ID=40336799
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0802537A Expired - Fee Related FR2930943B1 (fr) | 2008-05-07 | 2008-05-07 | Nouvelles utilisations de derives de d-mannopyranose inhibiteurs de l'angiogenese |
Country Status (6)
Country | Link |
---|---|
US (1) | US20110112044A1 (fr) |
EP (1) | EP2280985A2 (fr) |
JP (1) | JP2011520803A (fr) |
CA (1) | CA2723768A1 (fr) |
FR (1) | FR2930943B1 (fr) |
WO (1) | WO2009138601A2 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010125445A1 (fr) * | 2009-04-28 | 2010-11-04 | Pharmaxis Pty Ltd. | Composés phosphotétrahydropyrane pour le traitement de lésions et de troubles de type « fibreux » |
CN103601767B (zh) * | 2013-11-03 | 2016-06-29 | 大连九信生物化工科技有限公司 | 一种4,6-二羟基保护的葡萄吡喃己糖衍生物的脱保护方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9116896D0 (en) * | 1991-08-06 | 1991-09-18 | Erba Carlo Spa | 3-deoxymannosamine derivatives and process for their preparation |
AU2005258231A1 (en) * | 2004-06-23 | 2006-01-05 | Angiotech Pharmaceuticals (Us), Inc. | Methods and crosslinked polymer compositions for cartilage repair |
US20080057072A1 (en) * | 2006-08-31 | 2008-03-06 | Alcon Manufacturing, Ltd. | Antagonists of ci-m6p/igf2r for prevention and treatment of ctgf-mediated ocular disorders |
-
2008
- 2008-05-07 FR FR0802537A patent/FR2930943B1/fr not_active Expired - Fee Related
-
2009
- 2009-05-05 EP EP09745920A patent/EP2280985A2/fr not_active Withdrawn
- 2009-05-05 CA CA2723768A patent/CA2723768A1/fr not_active Abandoned
- 2009-05-05 JP JP2011507963A patent/JP2011520803A/ja active Pending
- 2009-05-05 WO PCT/FR2009/000525 patent/WO2009138601A2/fr active Application Filing
- 2009-05-05 US US12/991,631 patent/US20110112044A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2011520803A (ja) | 2011-07-21 |
US20110112044A1 (en) | 2011-05-12 |
WO2009138601A2 (fr) | 2009-11-19 |
EP2280985A2 (fr) | 2011-02-09 |
FR2930943A1 (fr) | 2009-11-13 |
WO2009138601A3 (fr) | 2010-03-04 |
CA2723768A1 (fr) | 2009-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR19C1033I2 (fr) | Derives phosphores servant d'inhibiteurs de kinase | |
FR20C1027I2 (fr) | Derives de tiglien-3-one | |
DOP2007000084A (es) | Derivados de dihidropirazolopirimidinona | |
BRPI0814457A2 (pt) | Derivados de imidazolona, composições farmacêuticas, utilização de derivados de imidazolona, e, processo de síntese de derivados de imidazolona | |
BRPI0907563A2 (pt) | Derivados de 4,5-di-hidro-xazol-2-il amina | |
BRPI0911764A2 (pt) | inibidores cíclicos de 11beta-hidroxiesteroide desigrogenase 1 | |
ATE496029T1 (de) | Derivate von 1-phenyl-2-pyridinylalkylenalkohole als phosphodiesteraseinhibitoren | |
CR10400A (es) | Derivados de lactamas de ciclohexilpirazol como inhibidores de 11-beta -hidroxiesteroide deshidrogenasa 1 | |
SMT201400009B (it) | Derivati eteroaromatici di ariltriazolo come inibitori dell'enzima pde 10A | |
ATE555107T1 (de) | 2-aza-bicyclo-ä2,2,1-üheptan-derivate | |
ATE496051T1 (de) | Pyrazolotetrahydropyridinderivate als orexinrezeptorantagonisten | |
ATE549340T1 (de) | Spiroindolinon-derivate als mdm2-p53 inhibitoren | |
BRPI0715617A2 (pt) | Derivados do ácido fenoxifenilacético 4-substituído | |
DE602006019624D1 (de) | Piperidin-4-yl-pyridazin-3-yl-aminderivate als schnell dissoziierende antagonisten des dopamin-2-rezeptors | |
SMT201400114B (it) | Derivati di 2-arilimidazolo come inibitori dell'enzima pde10a | |
DE602006010508D1 (de) | Substituierte triazolderivate als oxytocinantagonisten | |
BRPI1013853A2 (pt) | composições tópicas estáveis de derivados de 1,2,4-tiadiazol | |
CR10879A (es) | Cyclized derivatives as eg-5 inhibitors | |
DK1885805T3 (da) | Vandig overtrækssammensætning | |
ATE499367T1 (de) | 1,3-dihydroimidazol-2-thionderivate als inhibitoren von dopamin-beta-hydroxylase | |
FR2902426B1 (fr) | Derives de cinnamoyl-piperazine | |
FR2921232B1 (fr) | Composition d'aerosol aqueuse | |
CR10809A (es) | Derivados de heteroaril-pirrolidinil-y-piperidinil-cetona | |
BRPI0820779A2 (pt) | Derivados de 4-amino-pirimidina | |
BRPI1008173A2 (pt) | "derivados de piridina espiroindolinona" |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |
Effective date: 20150130 |